Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Food Allergy
TEHITI
1 other identifier
interventional
90
1 country
5
Brief Summary
This interventional study aims to validate an early heated protein introduction protocol in cow's milk allergic children who already developed tolerance towards extensively heated cow's milk, in order to speed up the development of complete cow's milk tolerance. Natural complete tolerance induction towards cow's milk takes several years of strict cow's milk avoidance with high risk of anaphylaxis by accidental cow's milk intake. By shortening the time towards complete tolerance, not only the quality of life of both children and parents ameliorates drastically, the time frame for potential anaphylactic reactions is also strongly reduced and can be considered as a preventive strategy to reduce allergic reactions too. Moreover, this strategy has proved efficient for hen's egg allergy. The main question this study wants to answer is whether a 12 months stepwise heated cow's milk introduction (either by gradual reduction of the cooking time or by the use of the Flemish Milk Ladder) in 20'-cooked cow's milk tolerant subjects, results in a larger proportion of complete cow's milk tolerant children after 12 months compared to natural tolerance induction (with 20' cooked milk introduction only).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2024
CompletedStudy Start
First participant enrolled
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2029
May 16, 2024
May 1, 2024
4.7 years
March 19, 2024
May 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Complete cow's milk tolerance after 12 months of stepwise heated cow's milk introduction
We here want to test the hypothesis that a total period of 12 months stepwise heated cow's milk introduction (either by gradual reduction of the cooking time or by the use of the Flemish Milk Ladder) in 20'-cooked cow's milk tolerant subjects, results in a larger proportion of complete cow's milk tolerant children after 12 months compared to natural tolerance induction (with 20' cooked milk introduction only).
12 months
Secondary Outcomes (6)
Time to complete tolerance in all three arms
12 months
Quality of life in all three arms
12 months
Clinical reactions
12 months
Side effects
12 months
IL-10-producing cow's milk specific regulatory T and B cells
Three times in 12 months
- +1 more secondary outcomes
Study Arms (4)
Stepwise introduction using gradually shorter heating of cow's milk proteins
OTHERStep 1: open introduction of 20' cooked cow's milk (at least 10 mL per portion, 2-3X a week) for 3 months. Step 2: open introduction of 15' cooked cow's milk (at least 10 mL per portion, 2-3X a week) for 3 months. Step 3: open introduction of 10' cooked cow's milk (at least 10 mL per portion, 2-3X a week) for 3 months. Step 4: open introduction of 5' cooked cow's milk (at least 10 mL per portion, 2-3X a week) for 3 months.
Stepwise introduction using the Flemish Milk Ladder
OTHERThe first 5 steps of the Flemish Milk Ladder (each containing a, b and c part) will be gradually introduced at home, each step for 21 days (2-3X a week during 3 consecutive weeks after which 3 days "rest"). We consider the 6th step the equivalent of tolerance induction so step 6 will be allowed once the OFC with uncooked milk is passed.
Control arm with introduction of 20' cooked cow's milk
OTHERStep 1: open introduction of 20' cooked cow's milk (at least 10 mL per portion, 2-3X a week) for 12 months.
Healthy age-matched subjects
OTHERFor work package 2, 15 healthy age-matched subjects are included to compare immunological mechanisms with.
Interventions
Implementation of cow's milk in decreasingly heated forms in cow's milk allergic subjects, tolerant to heated cow's milk, to assess the influence on tolerance induction.
Implementation of heated cow's milk in cow's milk allergic subjects, tolerant to heated cow's milk, to assess the influence on tolerance induction.
Eligibility Criteria
You may qualify if:
- Children (1-18y) had or have a clinical diagnosis of IgE mediated cow's milk allergy based on positive history as well as skin prick testing and/or specific IgE detection by CAPtest in an allergy clinic.
- Children are at least 12 months old before introduction of heated cow's milk is considered.
- Children did not suffer from grade 4 anaphylaxis due to cow's milk-ingestion at presentation.
- Children have specific IgE levels to Bos d 8 below 1.2 kU/mL and/or children passed 20' cooked cow's milk provocation test executed on clinical judgement.
You may not qualify if:
- Children had grade 4 anaphylaxis due to cow's milk ingestion.
- Children are younger than 12 months old at the moment of passing 20' cooked cow's milk OFC.
- Parents are not able or not willing to adhere to a specific cow's milk protein-containing diet on a regular basis at home.
- Multiple food allergy, not compatible with any of the choices in the Flemish Milk Ladder.
- Parents and/or children are not willing to give IC/assent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Imelda Hospital Bonheiden
Bonheiden, Belgium
AZ Sint-Jan
Bruges, Belgium
AZ Maria Middelares
Ghent, Belgium
Jessa Hospital
Hasselt, Belgium
UZ Leuven Gasthuisberg
Leuven, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jasmine Leus, MD
Maria Middelares Hospital, Gent
- PRINCIPAL INVESTIGATOR
Katrien Coppens, MD
Imelda Hospital, Bonheiden
- PRINCIPAL INVESTIGATOR
Sophie Verelst, MD
KU Leuven and Jessa Hospital, Hasselt
- PRINCIPAL INVESTIGATOR
Kate Sauer, MD
AZ Sint-Jan AV
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinic Head in Pediatrics-Allergy at UZ Leuven, Head of the Allergy and Clinical Immunology Research group at KU Leuven (prof., dr.)
Study Record Dates
First Submitted
March 19, 2024
First Posted
April 24, 2024
Study Start
April 22, 2024
Primary Completion (Estimated)
December 30, 2028
Study Completion (Estimated)
December 30, 2029
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share